The Venture Codex Logo

The Venture Codex

Overview

Drug discovery and development for aging and associated diseases.

Total Raised

$271 M

Rounds

3

Links

Verticals

Biopharma
Biotechnology
Life Science
Therapeutics

Investment History

  1. Series D

    Feb 2024

    $170M

  2. Series C

    Dec 2020

    $90M

  3. Series A

    Jul 2017

    $11M

Team

Kristen Fortney

CEO & Co-Founder

Eric Morgen

Co-founder and COO

George Hartman

Consultant for Chemistry & Strategy

Peng Leong

Chief Business Officer